The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy is named sequence.txt and is 5,746 bytes in size.
1. Field of the Invention
The present invention relates to a Monascus purpureus mutant, and more particularly to a mutant of Monascus purpureus NTU 568, a nucleotide sequence for Monascus purpureus NTU 568 and primers for nucleotide sequence of Monascus purpureus NTU 568.
2. Description of the Prior Art
Recently, red yeast fermented products with multi functions are subject to more and more attention due to the flourishing development of health foods. In Asia, Monascus purpureus are applied in foods and medicines for thousands years, wherein the secondary metabolites of Monascus purpureus can be divided into four kinds of:
Monascus purpureus NTU 568 is an excellent local Monascus purpureus strain, and which is studied and developed by Tzu-Ming PAN, the graduate chair of Institute of Microbiology and Biochemistry of National Taiwan University, and the R&D team thereof. Besides, currently, the health-care characteristics of preventing Alzheimer's disease, hypolipidemic effect and antioxidative of the red mold (RM) powder manufactured by using the Monascus purpureus NTU 568 have been proven, wherein the health-care characteristics of preventing Alzheimer's disease, hypolipidemic effect and antioxidative of the RM powder is carried out by the secondary metabolites of monacolins, ankaflavin and monacsin.
Nowadays, the Monascus purpureus NTU 568 is successful to be commercialized. However, in spite of that, the strain (mutant) identification and the DNA molecular marker of the Monascus purpureus NTU 568 does still not be carried out, wherein the DNA molecular marker technology is usually used for identifying the DNA sequence or the RAPD genetic variation map.
Accordingly, in view of the specific DNA sequence, the specific RAPD genetic variation map, and the DNA molecular marker of the Monascus purpureus NTU 568 still does not be finished, the inventor of the present application has made great efforts to make inventive research thereon and eventually provided a mutant of Monascus purpureus NTU 568, a nucleotide sequence for Monascus purpureus NTU 568 and primers for nucleotide sequence of Monascus purpureus NTU 568.
The primary objective of the present invention is to provide a mutant of Monascus purpureus NTU 568, a nucleotide sequence for Monascus purpureus NTU 568 and primers for nucleotide sequence of Monascus purpureus NTU 568, therefore the person skilled in Monascus purpureus filed is able to carried out the strain (mutant) identification of the Monascus purpureus NTU 568 according to the present invention. Moreover, the person skilled in Monascus purpureus filed can also rapidly complete the strain (mutant) identification of the Monascus purpureus NTU 568 by using DNA molecular marker technology, without culturing any isolated Monascus purpureus strain or live Monascus purpureus bacteria.
Accordingly, to achieve the primary objective of the present invention, the inventor of the present invention provides a Monascus purpureus mutant, which is Monascus purpureus NTU 568 having a nucleotide sequence of SEQ ID NO 1, SEQ ID NO 2 or SEQ ID NO 3. The Monascus purpureus NTU 568 was deposited with Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSMZ, Inhoffenstr. 7B, D-38124 Braunschweig, Germany) on Nov. 18, 2013, with the accession number of DSM 28072. Moreover, the nucleotide sequence of the Monascus purpureus NTU 568 can be formed by treating the RAPD (Random Amplification of Polymorphic DNA) and the PCR (Polymerase Chain Reaction) process to a plurality of specific primers, wherein the specific primers comprising a first nucleotide sequence of SEQ ID NO 4, a second nucleotide sequence of SEQ ID NO5, a third nucleotide sequence of SEQ ID NO6, a fourth nucleotide sequence of SEQ ID NO7, a fifth nucleotide sequence of SEQ ID NO8, and a sixth nucleotide sequence of SEQ ID NO9.
The invention as well as a preferred mode of use and advantages thereof will be best understood by referring to the following detailed description of an illustrative embodiment in conjunction with the accompanying drawings, wherein:
To more clearly describe a Monascus purpureus mutant, nucleotide sequences for the Monascus purpureus mutant and primers for the nucleotide sequences of the Monascus purpureus mutant according to the present invention, embodiments of the present invention will be described in detail with reference to the attached drawings hereinafter. Monascus purpureus NTU 568 is an excellent local Monascus purpureus strain, and which is studied and developed by Tzu-Ming PAN, the graduate chair of Institute of Microbiology and Biochemistry of National Taiwan University, and the R&D team thereof. In the present invention, the Monascus purpureus NTU 568 has a specific nucleotide sequence of SEQ ID NO 1, SEQ ID NO 2 or SEQ ID NO 3 is deposited with Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH (DSMZ, Inhoffenstr. 7B, D-38124 Braunschweig, Germany) on Nov. 18, 2013, with the accession number of DSM 28072. The Monascus purpureus NTU 568 includes the characteristics of: growing rapidly, strong starch hydrolysis, high metabolites production. The basic culture medium for Monascus purpureus NTU 568 needs includes 2% rice powder, and the best culture temperature is 30° C., the best culture time is 48 hours and the best culture pressure is 1 atm.
Moreover, for verifying the viability of Monascus purpureus NTU 568, it moves the strain of Monascus purpureus NTU 568 from a slant tube to a culture medium of potato dextrose agar (PDA) for culturing. After 15-day culture, it digs and takes out three mycelium with the size of 1 cm3 from the PDA, and then disposes the three mycelium into a culture fluid having 2% rice powder for next-stage culture; therefore, after 48-hour culture, the Monascus purpureus NTU 568 reveals high viability because the culture fluid shows red color. Herein, it needs to further explain that, the storage method for Monascus purpureus NTU 568 is to culture the Monascus purpureus NTU 568 on a PDA medium disposed in a slant tube under the store temperature of 4° C.; moreover, the Monascus purpureus NTU 568 must be treated with one time sub-cultured per 3 months.
Next, in order to prove that the Monascus purpureus NTU 568 can indeed increase the production of monacolin K of the secondary metabolites, the various experiment results and data are presented as follows. Please refer to following table 1, which records the production of monacolin K extracted from fermented rice substrate and fermented dioscorea substrate which is fermented by using different
Monascus purpureus species. According to table 1, it can find that the production of monacolin K extracted from the fermented substrate fermented by using Monascus purpureus NTU 568 is highest no matter the substrate is rice or dioscorea.
purpureus
M. sp. CA 505
M.
purpureus NTU 568
M. sp. CH 001
M.
purpureus NTU 601
M.
purpureus NTU 301
M.
anka M13
M. sp. KT
Please refer to
Next, in order to prove that the Monascus purpureus NTU 568 can indeed increase the production of monascin and ankaflavin of the secondary metabolites, the various experiment data are presented as follows. Please refer to following table 2, which records the production of monascin and ankaflavin extracted from different red mold fermented products. From table 2, it can apparently find that red mold fermented product fermented by using the Monascus purpureus NTU 568 includes the monascin of 11.65 mg/0.5 g and the ankaflavin of 1.77 mg/0.5 g, but others red mold fermented products does not includes monascin and ankaflavin.
Monascus product
Monascus product (CPC)
Monascus product 1
Monascus product (Koda)
Monascus product
Monascus product
Monascus product 2
Monascus product 3
Monascus product
Monascus product
Monascus product
Monascus
purpureus
Furthermore, in order to identify the DNA sequence of the Monascus purpureus NTU 568, it obtain the whole genome sequence of the Monascus purpureus NTU 568 by way of pyrosequencing, wherein the whole genome sequence of the Monascus purpureus NTU 568 includes 3,326 contigs with the total sequence length of 247,174,841 bps. Moreover, in the 3,326 contigs, the largest length of a specific contig is 175,588 bps.
Next, the Aspergillus is taken as a reference species and the software of FGENESH (SoftBerry, Inc., NY, USA) is then used for analyzing and predicting the DNA sequence of the Monascus purpureus NTU 568. The analysis and predict result shows 8,191 sequence data of mRNA and protein, wherein the total sequence length of the mRNA is 13,140,800 bps. Therefore, the whole genome sequence of the Monascus purpureus NTU 568 and the mRNA and protein sequence data are further edited to a single FASTA file, and then the FASTA file is transformed into a BLAST data by using the software of BLAST+ (Boratyn et al., 2013) for executing the gene search and alignment.
The gene search and alignment are executed by using polyketide synthases (PKSs) mechanism and model. Please refer to following table 3, which records several PKS fragments in PKS conserved domain. Therefore, the gene alignment between the PKS fragments of M. pilosus mok A and the BLASTp data of the Monascus purpureus NTU 568 as well as the BLASTn data of the Monascus purpureus NTU 568 have been completed.
Therefore, the gene alignment results reveal that, besides the well-known PKS genomes of citrinin (Accession: AB243687.1), monacolin K (Accession: DQ176595.1) and PKS1 (Accession: AJ414729.1), the whole genome sequence of the Monascus purpureus NTU 568 further includes 7 candidate gene fragment in PKS conserved domain, wherein the 7 candidate gene fragment are named as PKSε, PKSθ, PKSγ, PKSκ, PKSδ, PKSα, and PKSσ recorded in following table 4. Moreover, after completing the DELTA-BLAST analysis, the PKS fragments of PKSγ, PKSδ and PKSα are regarded as new PKS fragments of M. purpureus which are never recorded or written in any literatures or data base.
Based above gene search and alignment results, it is able to assume that the gene fragment of PKSα may be a novel gene fragment (sequence) for the Monascus purpureus NTU 568. Therefore, as listed in the following Sequence Listing, the nucleotide sequence of PKSα is defined as SEQ ID NO 1, and the sequence length of the nucleotide sequence of SEQ ID NO 1 is 1,390 bps. Furthermore, the nucleotide sequence of PKSα is treated with a BLASTx sequence alignment, and the alignment results are recorded in following table 5.
marneffei ATCC
stipitatus ATCC
posadasii str. Silveira
posadasii C735 delta
Coccidioides
immitis
Coccidioides
immitis
stipitatus ATCC
Neofusicoccum
parvum UCRNP2
niger
niger CBS 513.88
Continuously, please refer to
Moreover, the gene fragment of PKSδ can also be assumed as a novel gene fragment (sequence) for the Monascus purpureus NTU 568. As listed in the following Sequence Listing, the nucleotide sequence of PKSδ is defined as SEQ ID NO 2, and the sequence length of the nucleotide sequence of SEQ ID NO 2 is 1,024 bps. In order to identify whether the assumption is correct or not, the nucleotide sequence of PKSδ is treated with a BLASTx sequence alignment, and the alignment results are recorded in following table 6.
clavatus NRRL 1
oxysporum f. sp.
Penicillium
digitatum
Colletotrichum
gloeosporioides Nara
Colletotrichum
gloeosporioides Nara
Penicillium
digitatum
Glomerella
graminicola M1.001
Aspergillus
nidulans
Colletotrichum
orbiculare MAFF
Magnaporthe
oryzae
Please refer to
stipitatus ATCC
winteri
clavatus NRRL 1
stipitatus ATCC
fischeri NRRL 181
oryzae RIB40
fumigatus A1163
fumigatus Af293
oryzae RIB40
flavus NRRL3357
Please refer to
Thus, through above descriptions, the novel gene fragments and the related nucleotide sequence of the Monascus purpureus NTU 568 have been introduced. Next, for the nucleotide sequence of the Monascus purpureus NTU 568 can be formed by treating the RAPD (Random Amplification of Polymorphic DNA) and the PCR (Polymerase Chain Reaction) process to a plurality of specific primers, the specific primers will be introduced in follows.
As the following table 8 shows, the primers designed by the software of Geneious 4.5.8 are recorded. According to the following Sequence Listing, the nucleotide sequence of primer PKSα F is defined as SEQ ID NO 4 and has 19 bp sequence length, the nucleotide sequence of primer PKSα R is defined as SEQ ID NO 5 and has 19 bp sequence length, the nucleotide sequence of primer PKSδ F is defined as SEQ ID NO 6 and has 20 bp sequence length, and the nucleotide sequence of primer PKSδ R is defined as SEQ ID NO 7 and has 20 bp sequence length. Moreover, according to the following Sequence Listing, the nucleotide sequence of primer PKSγ F is defined as SEQ ID NO 8 and has 20 bp sequence length, and the nucleotide sequence of primer PKSγ R is defined as SEQ ID NO 9 and has 20 bp sequence length.
Continuously, the primers listed in the table 8 are executed RAPD through PCR process, wherein the polymerase chain reaction cocktail contains 3 ng DNA, 20 nM primers, a 1× Exsel reaction buffer, 0.5 U Exsel DNA polymerase (Bertec Enterprise, Taipei, Taiwan), and 100 M dNTPs. The reaction conditions of the PCR is as described: (1) 35-cycle processes with 95° C. (5 min) for heating, 95° C. (30 sec) for heating and −62° C. (1 min) for cooling; and (2) 70° C. (10 min) for reaction. Moreover, after completing the PCR process, it is able to execute the electrophoresis analysis for the PCR products by using 1% agarose gel, wherein the MISSION BIOTECH Co. Ltd. is commissioned to complete the electrophoresis analysis. After electrophoresis analysis and genome sequencing, it is able to confirm and prove that the PKSα, PKSγ and PKSδ are indeed the novel gene fragment (sequence) for the Monascus purpureus NTU 568.
Thus, through the descriptions, the mutant of Monascus purpureus NTU 568, nucleotide sequence for Monascus purpureus NTU 568 and primers for nucleotide sequence of Monascus purpureus NTU 568 of the present invention has been completely introduced and disclosed; in summary, the present invention has the following advantages:
In the present invention, the nucleotide sequence for Monascus purpureus NTU 568 and the primers for the nucleotide sequence are proposed in order to facilitate the person skilled in Monascus purpureus filed capable of carrying out the strain (mutant) identification of the Monascus purpureus NTU 568 according to the present invention. Moreover, the person skilled in Monascus purpureus filed can also rapidly complete the strain (mutant) identification of the Monascus purpureus NTU 568 by using DNA molecular marker technology, without culturing any isolated Monascus purpureus strain or live Monascus purpureus bacteria.
The above description is made on embodiments of the present invention. However, the embodiments are not intended to limit scope of the present invention, and all equivalent implementations or alterations within the spirit of the present invention still fall within the scope of the present invention.
This application is a continuation-in-part of U.S. application Ser. No. 12/946,823, filed on Nov. 15, 2010, the content of which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
Parent | 12946823 | Nov 2010 | US |
Child | 14142814 | US |